HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 41, Issue 2, Pages -
Publisher
Portland Press Ltd.
Online
2021-02-10
DOI
10.1042/bsr20202924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium‐glucose co‐transporters and diabetic nephropathy: Is there a link with toll‐like receptors?
- (2020) Zahra Ashrafi Jigheh et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
- (2019) Matthew Dodson et al. Redox Biology
- Inhibition of HMGB1 attenuates podocyte apoptosis and epithelial-to-mesenchymal transition (EMT) by regulating autophagy flux
- (2019) Juan Jin et al. Journal of Diabetes
- Ferroptosis, a new form of cell death: opportunities and challenges in cancer
- (2019) Yanhua Mou et al. Journal of Hematology & Oncology
- Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways
- (2019) Haidy E. Michel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Augmenter of liver regeneration protects the kidney from ischaemia‐reperfusion injury in ferroptosis
- (2019) Li‐li Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
- (2019) Yam Nath Paudel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- Emerging Role of Ferroptosis in Acute Kidney Injury
- (2019) Zhaoxin Hu et al. Oxidative Medicine and Cellular Longevity
- HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer
- (2019) Kim Jun Cheng et al. CELLULAR ONCOLOGY
- MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease
- (2018) Weiying Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice
- (2018) Xiaochen Chen et al. Scientific Reports
- Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
- (2018) Moataz Abdalkader et al. Frontiers in Neuroscience
- Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases
- (2018) Mingzhu Tang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The progression of HMGB1-induced autophagy in cancer biology
- (2018) Tianwei Xu et al. OncoTargets and Therapy
- The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1
- (2017) Li Xiao et al. Redox Biology
- Transcriptional Regulation by Nrf2
- (2017) Claudia Tonelli et al. ANTIOXIDANTS & REDOX SIGNALING
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Mechanisms of ferroptosis
- (2016) Jennifer Yinuo Cao et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search